Brief: Aerovate Therapeutics Inc Sees IPO Of Up To 7.15 Mln Shares Priced Between $13 And $15 Per Share
24/06/2021 11:14
June 24 (Reuters) - Aerovate Therapeutics Inc AVTE.O :
* AEROVATE THERAPEUTICS INC SEES IPO OF UP TO 7.15 MILLION
SHARES
OF COMMON STOCK PRICED TO BE BETWEEN $13 AND $15 PER SHARE - SEC
FILING
Further company coverage: AVTE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jade Biosciences
See all newsBrief: Jade Biosciences Announces Preclinical Data Characterizing Jade301, A Potentially Best-In-Class, Half-Life-Extended Anti-Ifn-Β Monoclonal Antibody In Development For Dermatomyositis, At Eadv 2026
U.S. RESEARCH ROUNDUP-Cardinal Health, Lumentum Holdings, Public Storage
Jade Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Jade Biosciences Q2 net loss widens as costs rise
Brief: Jade Biosciences, Inc Q2 Cash & Investments USD 461.2 Million